I agree that this site is using cookies. You can find further informations here.
X
van Steen, Cécile
37  results:
Search for persons X
?
1

Efgartigimod and Ravulizumab for Treating Acetylcholine Rec..:

van Steen, Cécile ; Celico, Lorenzo ; Spaepen, Erik...
Advances in Therapy.  41 (2024)  6 - p. 2486-2499 , 2024
Link: https://doi.org/10.1007/..
 
?
2

A latanoprost cationic emulsion (STN1013001) vs. other lata..:

Lazzaro, Carlo ; van Steen, Cécile ; Ghirelli, Giorgio...
Expert Review of Pharmacoeconomics & Outcomes Research.  23 (2023)  2 - p. 251-265 , 2023
Link: https://doi.org/10.1080/..
 
?
3

Viability of European cross-border access opportunities to ..:

Angelillo, Luigi ; van Steen, Cécile ; Ross-Stewart, Kirsty..
Health Policy and Technology.  12 (2023)  3 - p. 100752 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic..:

Lazzaro, Carlo ; van Steen, Cécile ; Aptel, Florent...
Journal of Ophthalmology.  2022 (2022)  - p. 1-13 , 2022
Link: https://doi.org/10.1155/..
 
?
5

Cost–Utility Analysis of a Latanoprost Cationic Emulsion (S..:

Lazzaro, Carlo ; van Steen, Cécile ; Billeit, Stephan...
Clinical Ophthalmology.  16 (2022)  - p. 323-337 , 2022
Link: https://doi.org/10.2147/..
 
?
6

Retinitis Pigmentosa: Burden of Disease and Current Unmet N..:

Cross, Nancy ; van Steen, Cécile ; Zegaoui, Yasmina..
Clinical Ophthalmology.  16 (2022)  - p. 1993-2010 , 2022
Link: https://doi.org/10.2147/..
 
?
7

How Useful Are Digital Health Terms for Outcomes Research? ..:

Burrell, Anita ; Zrubka, Zsombor ; Champion, Annette...
Value in Health.  25 (2022)  9 - p. 1469-1479 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Current and Future Treatment of Retinitis Pigmentosa:

Cross, Nancy ; van Steen, Cécile ; Zegaoui, Yasmina..
Clinical Ophthalmology.  16 (2022)  - p. 2909-2921 , 2022
Link: https://doi.org/10.2147/..
 
?
9

PP424 Piloting A Comprehensive Search For eHealth Definitio..:

Zrubka, Zsombor ; Burrell, Anita ; Sharkawy, Menna N...
International Journal of Technology Assessment in Health Care.  37 (2021)  S1 - p. 36-36 , 2021
Link: https://doi.org/10.1017/..
 
?
10

Cost–Utility Analysis of a Latanoprost Cationic Emulsion (S..:

Lazzaro, Carlo ; van Steen, Cécile ; Billeit, Stephan...
info:eu-repo/semantics/altIdentifier/doi/10.2147/OPTH.S351013.  , 2022
Link: https://www.dovepress.co..
 
?
11

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic..:

Lazzaro, Carlo ; van Steen, Cecile ; Aptel, Florent..
info:eu-repo/semantics/altIdentifier/doi/10.1155/2022/3837471.  , 2022
Link: https://hal.science/hal-..
 
?
12

Current and Future Treatment of Retinitis Pigmentosa:

Cross, Nancy ; van Steen, Cécile ; Zegaoui, Yasmina..
info:eu-repo/semantics/altIdentifier/doi/10.2147/OPTH.S370032.  , 2022
Link: https://www.dovepress.co..
 
?
13

Retinitis Pigmentosa: Burden of Disease and Current Unmet N..:

Cross, Nancy ; van Steen, Cécile ; Zegaoui, Yasmina..
info:eu-repo/semantics/altIdentifier/doi/10.2147/OPTH.S365486.  , 2022
Link: https://www.dovepress.co..
 
?
14

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic..:

LAZZARO, Carlo ; VAN STEEN, Cecile ; APTEL, Florent..
2090-004X (Print) 2090-004X (Linking).  , 2022
Link: https://oskar-bordeaux.f..
 
?
15

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic..:

Lazzaro, Carlo ; van Steen, Cecile ; Aptel, Florent..
info:eu-repo/semantics/altIdentifier/doi/10.1155/2022/3837471.  , 2022
Link: https://hal.science/hal-..
 
1-15